These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 9788619)

  • 1. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
    Krystal GW; DeBerry CS; Linnekin D; Litz J
    Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells.
    Krystal GW; Honsawek S; Kiewlich D; Liang C; Vasile S; Sun L; McMahon G; Lipson KE
    Cancer Res; 2001 May; 61(9):3660-8. PubMed ID: 11325836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.
    Krystal GW; Honsawek S; Litz J; Buchdunger E
    Clin Cancer Res; 2000 Aug; 6(8):3319-26. PubMed ID: 10955819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src family kinase activity is required for Kit-mediated mitogen-activated protein (MAP) kinase activation, however loss of functional retinoblastoma protein makes MAP kinase activation unnecessary for growth of small cell lung cancer cells.
    Bondzi C; Litz J; Dent P; Krystal GW
    Cell Growth Differ; 2000 Jun; 11(6):305-14. PubMed ID: 10910097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins.
    Krystal GW; Carlson P; Litz J
    Cancer Res; 1997 Jun; 57(11):2203-8. PubMed ID: 9187122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
    Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
    Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies.
    He H; Hirokawa Y; Levitzki A; Maruta H
    Cancer J; 2000; 6(4):243-8. PubMed ID: 11038144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.
    Krystal GW; Hines SJ; Organ CP
    Cancer Res; 1996 Jan; 56(2):370-6. PubMed ID: 8542594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
    Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
    Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.
    Buchdunger E; Cioffi CL; Law N; Stover D; Ohno-Jones S; Druker BJ; Lydon NB
    J Pharmacol Exp Ther; 2000 Oct; 295(1):139-45. PubMed ID: 10991971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src family-selective tyrosine kinase inhibitor, PP1, inhibits both Fc epsilonRI- and Thy-1-mediated activation of rat basophilic leukemia cells.
    Amoui M; Dráber P; Dráberová L
    Eur J Immunol; 1997 Aug; 27(8):1881-6. PubMed ID: 9295022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes.
    Kansra S; Stoll SW; Johnson JL; Elder JT
    Mol Pharmacol; 2005 Apr; 67(4):1145-57. PubMed ID: 15615697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells.
    Boney CM; Sekimoto H; Gruppuso PA; Frackelton AR
    Cell Growth Differ; 2001 Jul; 12(7):379-86. PubMed ID: 11457735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lck is involved in interleukin-2 induced proliferation but not cell survival in human T cells through a MAP kinase-independent pathway.
    Brockdorff J; Nielsen M; Kaltoft K; Mustelin T; Röpke C; Svejaard A; Geisler C; Odum N
    Eur Cytokine Netw; 2000 Jun; 11(2):225-31. PubMed ID: 10903801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases.
    McRae BL; Wallace C; Dixon KF; Roux A; Mohan S; Jia Y; Presky DH; Tracey DE; Hirst GC
    Int Immunopharmacol; 2005 Apr; 5(4):667-77. PubMed ID: 15710336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
    Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases.
    Tatton L; Morley GM; Chopra R; Khwaja A
    J Biol Chem; 2003 Feb; 278(7):4847-53. PubMed ID: 12475982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
    Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
    Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.